Skip to content
value.today

Quanta Therapeutics, Inc.

Total raised
$146 M
3 rounds on record
Latest round
$76 M
May 2023
First round on record
Oct 2021
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Quanta Therapeutics, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2023$76 MNo. 3$50 to $250 million

Quanta Therapeutics, Inc.: Raise no. 3, May 2023

Investors in this round

17 investors had bought by the notice of Jun 24, 2026: 17 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$76 M of $89 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Pitt · Executive Officer, Director
  • Derek Metzger · Executive Officer
  • Perry Nisen · Executive Officer, Director
  • Maha Katabi · Director
  • Maria Fardis · Director
  • Rajul Jain · Director
  • Ying Huang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Perry Nisen, Ceo. Newest notice filed Jun 24, 2026 (1 amendment). Read the notice at the SEC.

equitySEC
Feb 2023$30 MNo. 2$10 to $50 million

Quanta Therapeutics, Inc.: Raise no. 2, Feb 2023

Investors in this round

9 investors had bought by the notice of Feb 17, 2023: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$30 M of $30 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Cameron Pitt · Executive Officer, Director
  • Leonardo Faoro · Executive Officer
  • Perry Nisen · Executive Officer, Director
  • Arjun Goyal · Director
  • Maha Katabi · Director
  • Maria Fardis · Director
  • Samuel Saks · Director
  • Ying Huang · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Perry Nisen, Chief Executive Officer. Newest notice filed Feb 17, 2023. Read the notice at the SEC.

equitySEC
Oct 2021$40 MNo. 1$10 to $50 million

Quanta Therapeutics, Inc.: Raise no. 1, Oct 2021

Investors in this round

10 investors had bought by the notice of Nov 3, 2021: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $70 M offered; $30 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Perry Nisen · Executive Officer, Director
  • Arjun Goyal · Director
  • Cameron Pitt · Director
  • Maha Katabi · Director
  • Maria Fardis · Director
  • Samuel Saks · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Perry Nisen, Chief Executive Officer. Newest notice filed Nov 3, 2021. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Quanta Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).

    SEC Form D · Jun 2026

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jun 2026

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Quanta Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Quanta Therapeutics, Inc.
NameRoleNamed in
Cameron PittExecutive officerJun 2026
Derek MetzgerExecutive officerJun 2026
Perry NisenExecutive officerJun 2026
Leonardo FaoroExecutive officerMay 2023
Cameron PittDirectorJun 2026
Maha KatabiDirectorJun 2026
Maria FardisDirectorJun 2026
Perry NisenDirectorJun 2026
Rajul JainDirectorJun 2026
Ying HuangDirectorJun 2026
Arjun GoyalDirectorMay 2023
Samuel SaksDirectorMay 2023